LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer. [PDF]
Kumaraswamy A +14 more
europepmc +1 more source
Targeting endoplasmic reticulum stress and nitroso-redox imbalance in neuroendocrine prostate cancer: the therapeutic role of nitric oxide. [PDF]
Firdaus F +13 more
europepmc +1 more source
Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer. [PDF]
Liu B +18 more
europepmc +1 more source
Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancer. [PDF]
Nakamura Y +9 more
europepmc +1 more source
Corrigendum to "A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network" EBioMedicine 2018 Sep: 35: 167-177. [PDF]
Lee AR, Gan Y, Tang Y, Dong X.
europepmc +1 more source
New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic. [PDF]
Cai M +9 more
europepmc +1 more source
Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study. [PDF]
Aggarwal R +18 more
europepmc +1 more source
A Hierarchy of Luminal Transcription Factors Defines AR Cistrome and Is Lost in Neuroendocrine Prostate Cancer. [PDF]
Keo V +5 more
europepmc +1 more source
Impact of Metastatic Microenvironment on Physiology and Metabolism of Small Cell Neuroendocrine Prostate Cancer Patient-Derived Xenografts. [PDF]
Agarwal S +11 more
europepmc +1 more source
Correction to "Alternative RNA Splicing of the GIT1 Gene Is Associated With Neuroendocrine Prostate Cancer". [PDF]
europepmc +1 more source

